6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid has been researched along with Cancer of Nasopharynx in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alajez, NM; Bastianutto, C; Gullane, P; Hui, AB; Liu, FF; Lo, KW; Ng, R; O'Sullivan, B; Shi, W; Yue, S | 1 |
1 other study(ies) available for 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid and Cancer of Nasopharynx
Article | Year |
---|---|
Targeted depletion of BMI1 sensitizes tumor cells to P53-mediated apoptosis in response to radiation therapy.
Topics: Animals; Apoptosis; Chromans; Disease Progression; Gene Expression Profiling; Gene Knockdown Techniques; Histones; Humans; Mice; Microarray Analysis; Nasopharyngeal Neoplasms; Nuclear Proteins; Polycomb Repressive Complex 1; Proto-Oncogene Proteins; Reactive Oxygen Species; Repressor Proteins; RNA, Messenger; RNA, Small Interfering; Transplantation, Heterologous; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2009 |